Physician

Christian Barlow, M.D.

According to 2025 Medicare claims, Christian Barlow, M.D. (NPI: 1477948271) practices internal medicine in the Winchester, VA-WV market, with the plurality of this provider's patient population coming from Winchester City, VA. This provider's primary affiliated billing organization is SHENANDOAH ONCOLOGY, PC (NPI: 1124381959; TIN: 454759270) and primary practice location at 22601-6906. Barlow is affiliated with the ACO West Virginia (ACO ID: A3563), Penn Medicine Healthcare Partners, LLC (ACO ID: A5318), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Barlow's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 511 traditional Medicare patients, billed 162,120 HCPCS/CPT codes, and received $3,006,852 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 826 prescription claims across 133 beneficiaries totaling $1,485,948 in drug costs, led by Jakafi (Ruxolitinib Phosphate). DME data shows 43 claims. Open Payments data shows 3 records totaling $79. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $9,897 to $3,006,852. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $4,367 and ending at $1,485,948. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	47	106	$9,897
2019	102	262	$22,140
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	159	26,819	$542,291
2023	467	106,057	$2,038,679
2024	511	162,120	$3,006,852

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	30	66	$4,367
2016	48	155	$9,088
2017	52	184	$11,810
2018	46	193	$18,579
2019	N/R	11	$703
2020	N/R	16	$419
2021	19	35	$3,026
2022	24	77	$2,786
2023	101	505	$366,017
2024	133	826	$1,485,948

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	43	$914

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	163	463	$96
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	110	192	$61
96375	Injection of additional new drug or substance into vein	121	723	$11
80053	Blood test, comprehensive group of blood chemicals	200	754	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	204	863	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jakafi	Ruxolitinib Phosphate	22	660	$384,848
Lenalidomide	Lenalidomide	16	448	$227,412
Revlimid	Lenalidomide	12	336	$214,501
Nubeqa	Darolutamide	11	330	$146,332
Abiraterone Acetate	Abiraterone Acetate	14	420	$22,485

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8999	Prescription drug, oral, chemotherapeutic, nos	N	N/R	11	$418
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	20	$358
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	12	$138

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$79	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christian Barlow, M.D.?

Tedicare shows public-source Medicare data for Christian Barlow, M.D. (NPI 1477948271), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christian Barlow, M.D. have ACO affiliation data?

Christian Barlow, M.D. is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563), Penn Medicine Healthcare Partners, LLC (MSSP, ACO ID A5318), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Christian Barlow, M.D.?

Christian Barlow, M.D. is linked to SHENANDOAH ONCOLOGY, PC (billing NPI 1124381959) in the available physician profile data.

Does Christian Barlow, M.D. have Open Payments data?

Christian Barlow, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.